In elderly glioblastoma patients with MGMT promoter-methylated glioblastoma, TMZ chemotherapy was associated with a longer event-free survival and a trend towards longer overall survival (OS) as compared to radiation therapy alone. The gene discussed is MGMT; the disease is glioblastoma.